Health and Wellness

Live Lighter media event hosted by Ms. Karen Davila

As obesity continues to grow as a key contributor to chronic diseases and strain on the healthcare system in the Philippines, Novo Nordisk has launched the “Live Lighter” movement, a multi-sector initiative designed to reshape public awareness and improve access to care.

Introduced at a media event in Makati City, the campaign promotes a change in perspective—encouraging people to see obesity not as a matter of personal choice alone, but as a complex, chronic condition influenced by biology, environment, and other underlying factors.

Me at the event

The launch of the “Live Lighter” movement highlights an important reminder that health issues like obesity are not simply about personal choices, but are shaped by a mix of biological, environmental, and social factors. It reinforces the need for a more compassionate and science-based understanding of obesity, along with better access to proper care and support systems in the Philippines.

“For almost 30 years, we have studied obesity not as a lifestyle issue, but as a chronic disease. Today is not just about introducing a new treatment option. It is about changing how a country understands obesity,” said Wei Sun, General Manager of Novo Nordisk Philippines. “Through Live Lighter, we aim to help Filipinos treat obesity right—with science, compassion, and with the support they deserve.”

Expanding access to science-based treatment

During the panel discussion

More than a platform for awareness, the Live Lighter movement also signals a step forward in how obesity is treated in the Philippines by introducing innovative, science-based treatment option that goes beyond traditional approaches.

The launch coincides with the introduction of a new prescription therapy based on semaglutide, a GLP-1 receptor agonist that works with the body’s biology to help regulate appetite, energy intake, and metabolic processes. By targeting the underlying mechanisms of obesity, this class of treatment represents a shift toward more holistic and medically guided care.

Dr. Christiana Vida Montefalcon, head of Clinical, Medical, Regulatory & Pharmacovigilance of Novo Nordisk Philippines, underscored that for many patients, obesity is not simply a matter of diet and exercise, but a chronic disease that could require long-term health management and medical treatment. As such, newer therapies can play a critical role particularly for individuals who have struggled to achieve or sustain weight loss through conventional methods alone.

“Advancements like these are changing the way we approach obesity care,” Dr. Montefalcon shared.

“They allow us to address the biological drivers of the disease, giving patients a more realistic and sustainable path toward better health.” “This is not just about weight loss,” she noted. “It is about the over-all health and condition of people living with obesity.”

Reinforcing this, Wei Sun added, “Live Lighter is more than a campaign. It is a commitment to change the way obesity is understood and managed in the Philippines. By bringing sciencebased care, including innovative treatments, closer to patients, we hope to empower more Filipinos to take control of their health in a sustainable and medically guided way.”

From stigma to science

Despite its growing prevalence, obesity continues to be framed largely around willpower and lifestyle choices, often delaying diagnosis and limiting access to appropriate care. Health experts at the launch emphasized that this outdated narrative can prevent people from seeking help and restrict the adoption of effective, evidence-based interventions.

“Treating obesity as a disease changes everything, from how patients are supported to how healthcare systems respond,” said Dr. Montefalcon. “It allows for earlier intervention, more comprehensive care, and better long-term outcomes.”

The Live Lighter movement brings together media, healthcare professionals, industry partners, and patient advocates to promote a more informed and compassionate approach; one that centers on patient realities and health outcomes, not just weight.

A growing public health priority

The initiative comes at a time when obesity is increasingly recognized as a major contributor to non-communicable diseases such as type 2 diabetes, cardiovascular disease, and certain cancers—placing a growing burden on individuals, families, and the healthcare system.

Recent findings from the Epidemiological Burden and Cost of Obesity in the Philippines (EpiCOb-PH) study highlight the scale of the challenge, estimating that obesity cost the Philippine economy approximately Php 1.9 trillion in 2025—equivalent to 7.3% of GDP—and could reach up to Php 2.7 trillion when overweight-related conditions are included.

As awareness grows, so does the urgency to address obesity through a more structured, science-based approach that integrates prevention, early intervention, and long-term care.

Collective action

Guest during the event His Excellency Franz-Michael Mellbin, Ambassador of Royal Danish Embassy Manila

Beyond treatment, the movement underscores the need for collective action across sectors to address obesity more effectively—from improving public understanding and reducing stigma to strengthening healthcare systems and expanding access to care.

“Addressing obesity requires more than awareness. It requires a shift in mindset across healthcare, policy, and society,” said Anand Shetty, vice president for Novo Nordisk Business Area Southeast Asia. “With Live Lighter, we are working to move from stigma to science, and from fragmented efforts to a more coordinated, patient-centered approach to care.”

The launch also emphasized the importance of global partnerships in advancing local health priorities, showing how shared expertise and innovation can help make evidence-based care more accessible to patients.

As the “Live Lighter” movement builds momentum, Novo Nordisk seeks to encourage a wider national dialogue—one that reframes obesity not as a personal failing, but as a serious and treatable disease.

“Because when we treat obesity right, we change lives, not just for individuals, but for families and communities,” Wei Sun continued. “That is the impact we hope to achieve through Live Lighter movement.”

Reference: https://www.bworldonline.com/health/2026/03/10/735218/obesity-cost-philippines-p1-9- trillion-in-2025-study/

POST COPY:

In celebration of World Water Day, SM Supermalls, through its corporate social responsibility arm, SM Cares, organized coastal cleanup activities across six locations with seven participating malls across nationwide, reinforcing its long-term commitment to environmental stewardship and sustainable waste management in its most-loved malls.

In observance of World Water Day, SM Supermalls, through its corporate social responsibility arm SM Cares, conducted coastal cleanup activities in six locations across seven participating malls nationwide, strengthening its long-term commitment to environmental protection and sustainable waste management in its most loved malls.

This year’s initiative placed greater focus on waste segregation education, helping volunteers and communities better understand proper sorting, recycling, and disposal practices. It also highlighted how everyday habits—from responsible waste disposal to recycling—are vital in safeguarding marine ecosystems.

The coastal cleanup activities took place across SM City La Union, SM City Urdaneta Central, SM City Tanza, SM City Daet, SM City Consolacion, SM Seaside City Cebu, and SM J Mall, bringing together communities in a shared effort to protect local coastal environments and divert waste away from the ocean.

During the cleanups, collected waste was carefully sorted and categorized, allowing participants to see firsthand the types of materials commonly found in coastal areas—from plastic packaging and beverage containers to other discarded items that threaten marine life and coastal habitats.

By focusing on waste analysis and segregation, raised awareness on the impact of improperly managed waste and encouraged Filipinos to adopt more responsible environmental practices in their daily lives.

These coastal cleanup activities form part of SM Supermalls’ broader environmental sustainability programs, aligned with the SM Green Movement and the company’s Waste-Free Future campaign.

“Protecting our coastal and marine environments requires a more proactive, end-to-end approach with the cleanups starting with education, deepening awareness, and sustaining collective action,” said Engr. Liza Silerio, Vice President for Corporate Compliance and Program Director for Environment and Sustainability of SM Supermalls. “By helping communities understand the importance of proper waste segregation and responsible waste management, we hope to inspire long-term behavioral change that benefits both people and the planet.”

The initiative also highlights the spirit of bayanihan, bringing together mall communities, environmental partners, and local stakeholders in a shared effort to care for the environment.

As SM Cares continues to strengthen its sustainability programs throughout the year, the public is encouraged to participate in upcoming environmental initiatives, including World Oceans Day Cleanup Drives in June, International Coastal Cleanup activities in September, and National Environmental Awareness Month initiatives in November.

Through continued initiatives like this, SM Cares keeps empowering communities to actively help protect the environment—all for Filipinos and all for the planet.

To find out more about SM Cares’ environmental programs and how you can join future activities, visit https://www.smsupermalls.com/smcares.

Pru Life UK is reinforcing its commitment to helping Filipinos lead healthier, more secure lives by simplifying and personalizing healthcare, while expanding access to comprehensive services through partnerships with The Medical City (TMC) and Hi-Precision Diagnostics (HPD).

Through its Gift of Health campaign, customers, agents, and employees can benefit from practical health offerings that support early detection, prompt intervention, and access to quality care.

A key feature of the campaign is a complimentary non-communicable disease (NCD) risk assessment with The Medical City, designed to identify potential risks for chronic conditions through interview-based screening. With the high prevalence of lifestyle-related illnesses developing quietly and without symptoms, early detection plays a crucial role in preventing complications and improving long-term health outcomes.

Eligible individuals can also benefit from savings on selected outpatient services from both The Medical City and Hi-Precision Diagnostics, as well as discounts on The Medical City inpatient services for selected critical illnesses. With medical inflation and out-of-pocket expenses on the rise, this add-on benefit makes quality healthcare more accessible and manageable.

In addition, they can enjoy access to personalized medical concierge support at The Medical City, with a dedicated care team helping guide them through every step of their healthcare journey: from priority scheduling of doctors’ and diagnostic appointments, to navigating their hospital visit with ease.

These services are available across all The Medical City locations (Ortigas, Clark, Iloilo, Pangasinan and South Luzon) and Hi-Precision Diagnostics’ 60+ clinics nationwide, providing greater convenience and access to trusted healthcare providers.

“The Gift of Health reflects our shift towards a more holistic approach in enhancing the lives of Filipinos, by delivering meaningful and relevant everyday benefits beyond just insurance protection,” said Wai CW Kwok, Pru Life UK interim Chief Customer & Marketing Officer. “By making preventive care and early detection more accessible, we empower our customers, agents, and employees to Count on PRU as they take charge of their wellbeing and enjoy greater peace of mind.”

The Gift of Health benefits are available until December 31, 2026, for eligible Pru Life UK policyholders who enroll and link their active plans through PRUServices, as well as for agents and employees.

new generation of weight management treatments signals a breakthrough in care

Backed by over a century of scientific leadership in obesity and diabetes care, global healthcare company Novo Nordisk is strengthening its commitment to improving treatment for people living with obesity in the Philippines, as a new wave of therapies becomes available to Filipino patients.

Central to this progress are glucagon-like peptide-1 (GLP-1) receptor agonists—medications that mimic a natural hormone in the body responsible for regulating hunger and blood sugar. These treatments help individuals feel fuller for longer, curb cravings, and better control their appetite, while also supporting improved blood sugar management for those with diabetes.

This dual benefit marks a significant shift in how obesity and related conditions are treated—not as matters of willpower, but as chronic diseases requiring medical care.

The rise of GLP-1–based treatments represent one of the most important breakthroughs in metabolic health in recent years. These medicines have, over time, demonstrated substantial and sustained weight loss outcomes in clinical studies—bringing obesity treatment closer to the effectiveness of surgical interventions, but in a less invasive form.

According to the National Library of Medicine, GLP-1 RA medications have revolutionized weight loss and can reduce body weight in obese patients by between 15% and 25% on average after about one year. Their mode of action is to mimic the endogenous GLP-1, an intestinal hormone that regulates glucose metabolism and satiety.

This evolution reflects decades of research into the biology of hunger, hormones, and weight regulation, culminating in therapies that address the root causes of obesity.

“We are entering a new era in obesity care in the country. One that is grounded in science, compassion, and long-term solutions,” said Wei Sun, general manager of Novo Nordisk Philippines. “For many years, people living with obesity have been left with limited options and significant stigma. Today, with advancements in treatments that work with the body’s natural systems, we could transform outcomes for patients across the Philippines.”

Patient safety

As these innovations become more accessible, Novo Nordisk emphasizes the importance of patient safety and proper medical guidance. The company urges patients to seek consultation with qualified healthcare professionals and to use only approved, regulated medicines.

With the growing global demand for weight management treatments, there has also been a rise in compounded or unregulated versions that may not meet the same standards of quality, safety, and efficacy.

“Patient safety must always come first,” Sun added. “We strongly advise against the use of unapproved or compounded alternatives that bypass strict regulatory processes. These products may pose serious health risks and do not offer the same assurance of safety and effectiveness as approved medicines.”

Beyond treatment availability, Novo Nordisk’s initiatives in the Philippines concentrate on raising awareness of obesity as a chronic illness, providing healthcare professionals with up-to-date medical education, and collaborating to increase access to safe, evidence-based care.

SM Southmall in the late 90’s. Located in the water-challenged area of Las Pinas, the mall was the first to have a sewage treatment plant (STP) for water recycling. It opened to the public in 1995, followed by SM Bacoor in 1997, saving a significant volume of water otherwise used for flushing.

Since its first efforts, water stewardship at SM Prime Holdings, Inc. (SM Prime) has advanced significantly. The programmatic Water for Tomorrow campaign goes beyond effective water management and recycling as part of its environmental sustainability plan.

For SM Supermalls, any significant investment in water security is a good chance to benefit people and the environment because of this pressing call to action to safeguard and preserve a vital resource.

Amplified impact

With 89 malls nationwide, SM Supermalls high-impact yet practical water management systems and circularity practices build long-term capacity for future water disruptions and reflect the malls’ greater ecosystem.

A community solution. At the launch of SM City Baguio’s Rainwater Treatment Facility
(RTF), innovation meets sustainability and sets a benchmark for water efficiency.

Having introduced sewage treatment plants nearly three decades ago, well before any compliance requirements, SM Supermalls also made significant investments in efficient low-flow fixtures and water-saving technologies to prevent unnecessary consumption at scale. In 2023, the first rainwater treatment facility by a mall opened in Baguio to convert rainwater into another potable resource, alleviating pressure on the local water grid.

At a cultural level, SM Supermalls becomes a living sustainability classroom where mallgoers, employees, and tenant-partners are made aware of its water, waste, and energy programs. Partnerships with NGOs, government agencies, and civic groups also sustain water conversations through the mall’s broad reach and are crucial to the sustainability agenda.

SM Cares engages communities, mallgoers, and tenants in water conservation initiatives
that inspire mindful consumption and collective action.

Embedding the message of water sustainability, SM Cares champions UN SDG6 – using every mall touchpoint and social media to create content on water conservation, access to safe water, sanitation, and hygiene for health and well-being

Water sustainability is a shared responsibility across all SM malls. SM Cares engages and promotes water conservation initiatives that inspire mindful consumption and collective action.

As a vital community hub, the malls promote the wider SM Green Movement campaign, empowering people to practice responsible water use.

The first mall to receive LEED Gold Certification in 2017, SM Aura’s wastewater treatment plant and smart water management technologies ensure responsible and efficient water use.

Building what matters, today

The vital significance of water promotes economic development and human activity. SM Prime’s holistic approach to water management prepares for future difficulties as climate issues intensify and impact water availability.

SM Supermalls helps larger partner-tenants with more than just compliance and profitability. In the same vein, it encourages the adoption of creative solutions by smaller companies and other stakeholders who rely on mall operations.

“The scale of what we are doing today for water is already proof that we are reaping the benefits of the innovative vision of our leadership,” says Steven T. Tan, President of SM Supermalls.

“What makes our programs truly meaningful is how they bring people and purpose together. It creates a ripple effect of sustainability that reaches beyond our walls,” said Tan.  ###

From Left to Right: Mr. Al Reburiano (Key Account Manager of Galderma Philippines – Aesthetics), Ms. Joy Cabrera (Commercial Excellence Head of Galderma), Ms. Christine Legaspi (Marketing and Customer Education Training Manager), Mr. Andy Chou (Head of Commercial Operations of Galderma), Mr. Ferdinand “Louie” Roxas (General Manager of Galderma Philippines), Mr. Benedict Sy (President and Co-Founder of Avignon Clinic), Mr. Christopher Cachuela (CEO and founder of Avignon Clinic), June Christine Chio, M.D (Medical Operations Manager), Eufronia Apple Cruz, M.D (Aesthetic Physician of Avignon Clinic), Nancy Gabiota, M.D (Certified Dermatologist of Avignon Clinic) and Ms. Michelle De Jesus (Business Unit Head of Galderma Philippines – Aesthetics)

In skincare news that will be sure to cause a buzz in the Philippine regenerative aesthetics scene, Avignon Clinic and Galderma, a global leader in dermatology and aesthetics, announce a strategic partnership aimed at advancing the standard of injectable treatments in the country. This alliance underscores a shared commitment to patient-centric innovation, clinical safety, and education in aesthetic care.

As patients continue to seek safe, effective, and personalized treatments, the collaboration between Avignon Clinic and Galderma aims to respond with science-backed solutions that evolve with individual skin needs. The partnership will feature cutting-edge injectables: notably Sculptra®, Restylane® Kysse and Restylane® Skinboosters Translucent Vital, designed to deliver natural, long-lasting results without compromising comfort or safety.

“This partnership is rooted in a shared vision, to elevate aesthetic medicine through innovation and trust,” said Ferdinand “Louie” Roxas, General Manager of Galderma Philippines. “By working with an institution like Avignon, which mirrors our values and commitment to excellence, we can bring global dermatological solutions to local patients who deserve the very best.”

Andy Chou, Head of Commercial Operations of Galderma, also highlighted the significance of the collaboration in the broader regional landscape. “Our partnership with Avignon Clinic aligns perfectly with our vision to expand access to advanced regenerative aesthetic solutions across Asia-Pacific with strong medical expertise with a patient-first philosophy.”

With a reputation for state-of-the-art facilities and a focus on tailored patient experiences, Avignon Clinic reinforces its leadership through this strategic alignment. According to Christopher Cachuela, Founder and CEO of Avignon Clinic, “This collaboration with Galderma enables us to offer not just world-class treatments, using evidence-based products that deliver high patient satisfaction and ensure safety for our patients. Our clients can expect the most advanced, clinically tested injectable solutions to meet their changing skin goals.”

A New Era for Injectables in the Philippines

The partnership spotlights three key innovations:

Sculptra®, often described as the foundation for youthful-looking skin, is the only collagen stimulator made with PLLA-SCA, a unique formulation proven to stimulate type 1 collagen—the most abundant form in the skin. Results begin as early as 14 days post-treatment and can last over two years, offering natural-looking firmness, radiance, and elasticity over time.

Restylane® Skinboosters Translucent Vital is the only hyaluronic acid (HA) injectable clinically proven to enhance six aspects of skin quality. Patients can expect deep hydration, improved smoothness, reduced fine lines, even tone, reduced scarring, and a refreshed glow that lasts up to 15 months.

Restylane® Kysse is a hyaluronic acid (HA) lip filler designed specifically with movement in mind, made with Optimal Balance Technology (OBT). This advanced formulation allows for precise, natural-looking results that move harmoniously with every smile, and expression. Whether a more defined lip contour, improving lip symmetry, achieving naturally full lips, or smoothing perioral lines (commonly known as smoker’s lines), Restylane Kysse is the ideal choice for patients seeking personalized, expressive beauty that complements their unique facial features.

“More than just treatments, these injectables represent confidence,” said Michelle De Jesus, Business Head of Galderma Aesthetics Philippines. “We understand patients’ apprehensions about injectables, and that’s why we’re focused on education, transparency, and the use of rigorously tested products that deliver subtle, natural improvements.”

What’s Next: Forward-Thinking Aesthetic Programs

As part of this partnership, Avignon and Galderma will roll out a series of educational campaigns, exclusive treatment programs, and medical symposia to further demystify aesthetic injectables and empower patients to make informed choices.

“There’s a lot of misconceptions around injectables, because some think it’s about changing who you are. But at Avignon, our philosophy is enhancement, not alteration,” noted Benedict Sy, President of Avignon Clinic. “By partnering with Galderma, we’re confident in providing results that feel natural, look refined, and will age gracefully with our patients.”

This partnership signifies a mutual dedication to raising industry standards while nurturing the growing trust Filipino patients place in aesthetic medicine.

For more information about Avignon Clinic and its partnership with Galderma, follow Avignon Clinic and Galderma Aesthetics Philippines on Facebook, Avignon Clinic and Galaderma Aesthetics Philippines on Instagram or speak to an Avignon skin specialist today.

Together, Novo Nordisk and MedGrocer have launched ForwardMG by MedGrocer, the first cardiometabolic-focused ePharmacy in the Philippines that supports individuals with obesity and other chronic illnesses. With MedGrocer’s experience in digital healthcare and Novo Nordisk’s scientific leadership, the partnership seeks to make high-quality care more patient-centered, approachable, and less frightening. Through a single, integrated platform, ForwardMG offers a comprehensive care ecosystem, including access to physicians, medications, dietitians, and mental health assistance. Over a million Filipinos are already served annually by MedGrocer’s digitally connected healthcare solutions, and this collaboration furthers the company’s goal of revolutionizing chronic illness treatment in the nation. This program is also a component of Novo Nordisk’s Truth About Weight (TAW) campaign, which aims to increase knowledge, fight stigma, and support evidence-based, well-informed ways to treating obesity. (L-R) Geraldine Perez, Novo Nordisk Philippines’ director of market access and business development; Wei Sun, Novo Nordisk Philippines’ general manager; Germaine Kaw, co-founder and co-CEO of MedGrocer; and Raphael Santos, MedGrocer’s wellness lead.